| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 8729 | 2021 |
| Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease TF Outeiro, E Kontopoulos, SM Altmann, I Kufareva, KE Strathearn, ... science 317 (5837), 516-519, 2007 | 1112 | 2007 |
| Yeast cells provide insight into alpha-synuclein biology and pathobiology TF Outeiro, S Lindquist Science 302 (5651), 1772-1775, 2003 | 925 | 2003 |
| α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells C Hansen, E Angot, AL Bergström, JA Steiner, L Pieri, G Paul, TF Outeiro, ... The Journal of clinical investigation 121 (2), 715-725, 2011 | 847 | 2011 |
| Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein S Willingham, TF Outeiro, MJ DeVit, SL Lindquist, PJ Muchowski Science 302 (5651), 1769-1772, 2003 | 507 | 2003 |
| Formation of toxic oligomeric α-synuclein species in living cells TF Outeiro, P Putcha, JE Tetzlaff, R Spoelgen, M Koker, F Carvalho, ... PloS one 3 (4), e1867, 2008 | 448 | 2008 |
| Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ... Experimental neurology 213 (2), 315-325, 2008 | 411 | 2008 |
| SIRT1 and SIRT2: emerging targets in neurodegeneration G Donmez, TF Outeiro EMBO molecular medicine 5 (3), 344-352, 2013 | 371 | 2013 |
| Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington’s and Parkinson’s diseases RA Bodner, TF Outeiro, S Altmann, MM Maxwell, SH Cho, BT Hyman, ... Proceedings of the National Academy of Sciences 103 (11), 4246-4251, 2006 | 329 | 2006 |
| Alpha-synuclein: from secretion to dysfunction and death O Marques, TF Outeiro Cell death & disease 3 (7), e350-e350, 2012 | 314 | 2012 |
| Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease M Martins, A Rosa, LC Guedes, BV Fonseca, K Gotovac, S Violante, ... PloS one 6 (10), e25443, 2011 | 249 | 2011 |
| Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation MJ Diógenes, RB Dias, DM Rombo, HV Miranda, F Maiolino, P Guerreiro, ... Journal of Neuroscience 32 (34), 11750-11762, 2012 | 237 | 2012 |
| Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro IL Derkatch, SM Uptain, TF Outeiro, R Krishnan, SL Lindquist, ... Proceedings of the National Academy of Sciences 101 (35), 12934-12939, 2004 | 237 | 2004 |
| Interactions among α-synuclein, dopamine, and biomembranes JC Rochet, T Fleming Outeiro, KA Conway, TT Ding, MJ Volles, ... Journal of Molecular Neuroscience 23 (1), 23-33, 2004 | 229 | 2004 |
| Protein phosphorylation in neurodegeneration: friend or foe? S Tenreiro, K Eckermann, TF Outeiro Frontiers in molecular neuroscience 7, 42, 2014 | 225 | 2014 |
| Small heat shock proteins protect against α-synuclein-induced toxicity and aggregation TF Outeiro, J Klucken, KE Strathearn, F Liu, P Nguyen, JC Rochet, ... Biochemical and biophysical research communications 351 (3), 631-638, 2006 | 218 | 2006 |
| Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models LJ Su, PK Auluck, TF Outeiro, E Yeger-Lotem, JA Kritzer, DF Tardiff, ... Disease models & mechanisms 3 (3-4), 194-208, 2010 | 202 | 2010 |
| Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation DF Lázaro, EF Rodrigues, R Langohr, H Shahpasandzadeh, T Ribeiro, ... PLoS genetics 10 (11), e1004741, 2014 | 196 | 2014 |
| α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B DG Ferreira, M Temido-Ferreira, H Vicente Miranda, VL Batalha, ... Nature neuroscience 20 (11), 1569-1579, 2017 | 190 | 2017 |
| Dopaminergic neuron loss and up‐regulation of chaperone protein mRNA induced by targeted over‐expression of alpha‐synuclein in mouse substantia nigra JL St Martin, J Klucken, TF Outeiro, P Nguyen, C Keller‐McGandy, ... Journal of neurochemistry 100 (6), 1449-1457, 2007 | 190 | 2007 |
Sandra TenreiroCEDOC- Centro de Estudos de Doenças Crónicas, Lisbon, PortugalVerified email at nms.unl.pt
